A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy
about
Homologous-recombination-deficient tumours are dependent on Polθ-mediated repairHomologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian CancerComparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerPARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesStroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulationCisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian TumorsMás-o-menos: a simple sign averaging method for discrimination in genomic data analysis.Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast CancerImproved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmDiscrete mixture modeling to address genetic heterogeneity in time-to-event regressionPanel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer.Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.MAVTgsa: an R package for gene set (enrichment) analysis.A four-long non-coding RNA signature in predicting breast cancer survival.The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.A genomic instability score in discriminating nonequivalent outcomes of BRCA1/2 mutations and in predicting outcomes of ovarian cancer treated with platinum-based chemotherapyIdentification of reproducible gene expression signatures in lung adenocarcinoma.Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer.Ovarian cancer : making its own rules-again.Ovarian cancer: in search of better marker systems based on DNA repair defectsOptimized Prediction of Extreme Treatment Outcomes in Ovarian Cancer.A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinomaDNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy.Predicting time to ovarian carcinoma recurrence using protein markers.A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis.Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer PatientsPoly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.A long non-coding RNA signature to improve prognosis prediction of gastric cancer.Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.Prognostic biomarkers in endometrial and ovarian carcinoma.Ovarian cancer: diagnostic, biological and prognostic aspects.Frontline treatment of epithelial ovarian cancer.A molecular portrait of microsatellite instability across multiple cancersCritical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.
P2860
Q24317107-293E7D76-28B7-40CA-A28C-DDE3B569502AQ26783551-36EAAA9C-E653-4BA6-BD79-1BEE0324C538Q26859166-537218F8-5D39-456C-9E9A-16FFE8E26DB5Q27027503-B91E3426-83A0-4A3E-A2CC-AF1F0E182EC2Q27307642-A22D6DE3-0A28-4D78-B026-E4CE7723958AQ28066991-E013DAAE-9B9A-4353-859B-857ECD615D3BQ28550863-8F98BFD3-E5A0-431B-8EA4-D3368308513EQ30838620-CDA8315F-FE54-493E-997A-9EF5660AE202Q31132980-8243D70A-8A04-495D-992E-B9067D92E521Q33731278-543D2AF5-906B-4774-A772-C94BC4DB6641Q33760422-46C5E467-8F60-4832-A355-E258FB4FED6CQ33783847-0A5F0E88-B9B3-4E5F-AC73-C1388801026FQ33793232-743C5BA1-CE29-42A4-B1E7-F682365BBF93Q33914502-7A75A265-2A73-4B54-87A5-A294092D2107Q34346056-446B632A-C7E0-4BD7-84E3-019470A54A6BQ34455481-C4982340-CF32-4BE6-995B-61482526D8B7Q34599539-32C8336F-DCF7-4F97-9068-608B05D4539FQ35076226-092CC436-7939-4719-B264-B54BC6C510F7Q35147619-1134B085-F5AC-455B-A7AE-366F9D2DAA7AQ35212386-6D7B7D4C-76DB-4A2C-8804-66A3A6F103E7Q35952814-CA3EF81E-A5DD-4F9F-B6AC-073BD73525FEQ36402747-9C79B6F5-8879-4522-A325-E026ADEF701BQ36557043-CDC7FB38-326C-44FB-9651-CE5CF32AC515Q36589947-30618089-64B4-4F8B-8828-109037812AE1Q36726141-4B13E1D0-D8CD-46A7-AEF1-2DC2527256B0Q36772106-13245CD7-F88F-47A8-A8C0-DAE5859A940EQ36956378-CF539E0D-F2BA-480C-8262-8F0B7B24948EQ37123908-46B10279-4686-479D-81EC-B56B0A293793Q37157371-D131D942-C785-4698-BE8F-8BA67EAC7DFAQ37211342-144BA32A-A109-4E5E-8F00-390C696A42D2Q37237962-DE43292D-73CD-4067-8425-EA987DA642D9Q37268013-C649CDB3-4589-4CF1-BC00-91AF0FC06136Q37309678-7CB3078A-B906-47D3-AEBA-B53199E1B5DCQ37362685-79C767CE-6D34-44B8-BC82-613EC07DA4A7Q37469856-3E03B70A-884F-4172-A84B-4EA6D76AFEE9Q38185940-56894526-0017-470B-BE6C-7F8677958F84Q38261795-A0AFAEE3-9F40-4557-85D3-469E6A63B327Q38669746-DADED565-1DCE-405F-A044-5EA8BF5F2C98Q38741312-3E1319A5-F76F-4E20-9DD1-6A6C1CBA68D1Q40646057-C76DCC38-04C9-4A2B-AB74-1BF29C1F2501
P2860
A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@ast
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@en
type
label
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@ast
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@en
prefLabel
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@ast
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@en
P2093
P2860
P356
P1476
A DNA repair pathway-focused s ...... th platinum-based chemotherapy
@en
P2093
Alan D D'Andrea
David Kozono
Josephine Kang
P2860
P304
P356
10.1093/JNCI/DJS177
P407
P577
2012-04-13T00:00:00Z